Opus Genetics, Inc. SEC filings IRD

Opus Genetics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 17, 2005. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Mar 23, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 8, 2024 Dec 31, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Mar 24, 2022 Dec 31, 2021
10-K Annual report Mar 11, 2021 Dec 31, 2020
10-K/A Amended annual report Apr 29, 2020 Dec 31, 2019
10-K Annual report Feb 21, 2020 Dec 31, 2019
10-K Annual report Mar 7, 2019 Dec 31, 2018
10-K Annual report Mar 9, 2018 Dec 31, 2017
10-K Annual report Feb 24, 2017 Dec 31, 2016
10-K Annual report Mar 14, 2016 Dec 31, 2015
ARS Annual report to shareholders Apr 23, 2015 Dec 31, 2014
10-K Annual report Mar 16, 2015 Dec 31, 2014
ARS Annual report to shareholders Apr 30, 2014 Dec 31, 2013
10-K Annual report Mar 21, 2014 Dec 31, 2013
ARS Annual report to shareholders May 6, 2013 Dec 31, 2012
10-K Annual report Mar 22, 2013 Dec 31, 2012
ARS Annual report to shareholders May 3, 2012 Dec 31, 2011
10-K Annual report Mar 16, 2012 Dec 31, 2011
ARS Annual report to shareholders Apr 27, 2011 Dec 31, 2010
10-K/A Amended annual report Mar 23, 2011 Dec 31, 2010
10-K Annual report Mar 16, 2011 Dec 31, 2010
ARS Annual report to shareholders May 3, 2010 Dec 31, 2009
10-K Annual report Mar 31, 2010 Dec 31, 2009
ARS Annual report to shareholders Apr 24, 2009 Dec 31, 2008
10-K/A Amended annual report Mar 24, 2009 Dec 31, 2008
10-K Annual report Mar 16, 2009 Dec 31, 2008
ARS Annual report to shareholders May 9, 2008 Dec 31, 2007
ARS Annual report to shareholders May 17, 2007 Dec 31, 2006
ARS Annual report to shareholders May 22, 2006 Dec 31, 2005

Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IRD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1228627
Former names
Ocuphire Pharma, Inc. (until Oct 22, 2024); REXAHN PHARMACEUTICALS, INC. (until Nov 9, 2020); CORPORATE ROAD SHOW DOT COM INC (until Apr 29, 2005); FERRARO FRANK (until Apr 29, 2003)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.